Pharmagen, Inc.
9337 Fraser Avenue
Silver Spring, MD 20910
 
May 10, 2013
 
VIA EDGAR
 
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Attn: Pamela Howell
 
Re:   Pharmagen, Inc.
    Registration Statement on Form S-1
    File No. 333-186188

Ladies and Gentlemen:

Pursuant to Rule 477 under the Securities Act of 1933, we hereby request the withdrawal of the registrant's registration statement on Form S-1 originally filed on January 25, 2013, together with all exhibits thereto. The filing has not been declared effective. No securities have been sold or issued pursuant to the registration statement, and the registrant does not intend to sell or issue any securities in connection therewith.

Accordingly, the registrant requests that an order granting withdrawal of the registration statement be issued as soon as possible and be included in the file for the registration statement. The registrant also requests that all fees paid to the Securities and Exchange Commission in connection with the filing of the registration statement be credited to the registrant's account for future use.

Please contact me if you have any comments or questions regarding this application.

 
  Very truly yours,  
     
  /s/ Mackie Barch  
  Mackie Barch  
  President and Chief Executive Officer  
Grafico Azioni Pharmagen (CE) (USOTC:PHRX)
Storico
Da Gen 2025 a Feb 2025 Clicca qui per i Grafici di Pharmagen (CE)
Grafico Azioni Pharmagen (CE) (USOTC:PHRX)
Storico
Da Feb 2024 a Feb 2025 Clicca qui per i Grafici di Pharmagen (CE)